
Training AI to Detect Disease: Stand Up To Cancer’s Julian Adams
Episode 7
Julian Adams tried but didn’t succeed at retirement after a productive career as a medical chemist with several U.S. Food and Drug Association approvals of cancer-related treatments, including cell therapy for bone marrow transplantation. Soon after, his participation in a Stand Up To Cancer advisory group led to his appointment as the nonprofit’s president and CEO. The research organization raises money to advance the diagnosis of numerous cancers. Given rapid technological advancements, our podcast hosts were eager to invite Julian on the show to share how Stand Up To Cancer uses artificial intelligence to aid in this pursuit. Read the episode transcript here. For more information on Stand Up To Cancer and how to donate to the organization, please visit this website. Guest bio Julian Adams, president and CEO of Stand Up To Cancer, is among the world’s foremost oncology researchers. He was previously CEO of biopharmaceutical company Gamida Cell and president of R&D at Infinity Pharmaceuticals, where he oversaw development of small molecule drugs to treat cancer. He has also held roles at Millennium Pharmaceuticals, Boehringer Ingelheim, LeukoSite, and ProScript. Adams’s recognitions include the 2012 Warren Alpert Foundation Prize for his role in the discovery and development of bortezomib, an anti-cancer drug; the 2012 C.
Publisher
Me, Myself, and AI
Link
sloanreview.mit.edu/audio/training-ai-to-detect-disease-stand-up-to-cancers-julian-adams
Published
June 11, 2025
Duration
31 min
Format
Podcast
Category
Lifestyle · Education
Source
RSS feed
Host
MIT Sloan Management Review
Me, Myself, and AI
@memyselfandai
#trainingai #detectdisease #cancersjulianadams
